Dynamics of daily blood pressure monitoring in hypertensive patients with obesity exposed to combined anthihypertensive therapy


  • O. Ya. Babak
  • K. I. Tereshkin
  • V. V. Shkolnik




hypertonic disease, obesity, daily blood pressure monitoring, combined antihypertensive therapy


The study of the features of daily monitoring of blood pressure in patients with essential hypertension by obesity compared with patients with essential hypertension without excess weight was done. Combined therapy with amlodipine and olmesartan leads to a signifi cant decrease in mean integral indicators and improve the circadian blood pressure.


Aneja A. Hypertension and obesity / A. Aneja, F. El-Atat, S.I. McFarlane, J.R. Sowers // Recent Progr. Horm. Res. – 2004. – Vol. 59. – P. 169–205.

Arbeeny C.M. Addressing the unmet medical need for safe and effective weight loss therapies / С. М. Arbeeny // Obes Res. – 2004. – V. 12, №8. – Р. 1191–1196.

Гуревич М.А. Место современных диуретиков в лечении артериальной гипертонии у пациентов с ожирением / А.М. Гуревич // Справочник поликлинического врача. – 2010. – №88. – С. 43–46.

Федорова Е.Ю. Механизмы прогрессирования поражения почек при ожирении / Е.Ю. Федорова, И.М. Кутырина // Нефрология и диализ. – Т. 8, №2.

Kramer H. Screening for kidney disease in adults with diabetes / H. Kramer H, M.E. Molitch // Diabetes Care. – 2005. – V. 28, №7. – Р. 1813–1816.

Rabmouni K. Obesity – associated Hypertension. New insights into mechanisms / K. Rabmouni, M.L.G. Correia, W.G. Haynes [et al.] // Hypertension. – 2005. – V. 45. – P. 9–14.

Братусь В.В. Ожирение, инсулинорезистентность, метаболический синдром: фундаментальные и клинические аспекты / В.В. Братусь, Т.В. Талева, В.А. Шумаков. – К.: Четверта хвиля, 2009. – 416 с.

Lassegue B. Reactive oxygen species in hypertension. An update / Lassegue B., Griendling KK. // AJH. – 2004. – V. 17. – P. 852–860.

Kuo J. Inhibition of NO sintesis enhances chronic cardiovascular and renal actions of leptin / Kuo J., Jones O.B., Hall J.E. // Hypertens. – 2001. – V. 37. – P. 670–676.

Лутай М.И. Роль дисфункции эндотелия, воспаления и дислипидемии в атеросклерозе / М.И. Лутай, И.П. Голикова, В.А.Слободской // Укр. Кард. Журнал. – 2007. – №5. – С. 37–42.

Ceconi C. Differences in the effect of angiotensin converting enzyme inhibitors on the rate on the rate of endothelial cell apoptosis: in vitro and in vivo studies / C. Ceconi, G. Francolini [et al.] // Cardiovasc. Drug Ther. – 2007. – V. 21. – P. 423–429.

ADVANCE Collaborative Group. Effects of fi xed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial / ADVANCE Collaborative Group // Lancet. – 2007. – V. 370. – P. 828–840.

How to Cite

Babak OY, Tereshkin KI, Shkolnik VV. Dynamics of daily blood pressure monitoring in hypertensive patients with obesity exposed to combined anthihypertensive therapy. Zaporozhye Medical Journal [Internet]. 2013Nov.13 [cited 2024May20];15(5). Available from: http://zmj.zsmu.edu.ua/article/view/18766



Original research